China Universal Asset Management Co., Ltd. - AMYLYX PHARMACEUTICALS INC ownership

AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 152 filers reported holding AMYLYX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of AMYLYX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$32
+68.4%
1,730
+96.6%
0.01%
+50.0%
Q2 2023$19
-26.9%
880
-1.9%
0.01%
-33.3%
Q1 2023$26
+4.0%
897
+33.3%
0.01%
-10.0%
Q4 2022$256730.01%
Other shareholders
AMYLYX PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,756,050$35,415,0003.44%
Boxer Capital, LLC 2,200,000$28,270,0001.45%
Alpha Wave Global, LP 617,220$7,931,0000.72%
Ikarian Capital, LLC 396,654$5,097,0000.67%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 768,603$9,877,0000.58%
Ikarian Capital, LLC 250,000$3,213,0000.42%
683 Capital Management, LLC 677,714$7,685,0000.41%
Perceptive Advisors 1,474,107$18,942,0000.38%
VIKING GLOBAL INVESTORS LP 7,170,536$92,141,0000.37%
Rock Springs Capital Management LP 998,307$12,828,0000.32%
View complete list of AMYLYX PHARMACEUTICALS INC shareholders